What Symphony Robotics does

Symphony Robotics is a Miami-based, privately held medical device company developing an MRI-guided, magnetically actuated micro-robotic platform for neurosurgical applications. The company's core product is described as the world's first MRI-guided steerable micro-robotic system capable of navigating the brain along non-linear, snake-like trajectories, controlled by AI algorithms. The flexible robotic arm is designed to bend, steer, and maneuver through complex brain anatomy to reach lesions previously considered inaccessible via conventional rigid surgical instruments, enabling energy delivery, biopsies, and targeted therapeutic agent delivery through a single minimally invasive entry point. The platform targets neurosurgeons and brain surgery centers treating patients with irregularly shaped or hard-to-reach brain pathologies, including brain tumors and drug-resistant epilepsy.

The technology remains investigational and has not been cleared or approved by the U.S. Food and Drug Administration. The company has been validated through more than a decade of research and has received over $12 million in cumulative non-dilutive grant funding from the National Institutes of Health (NIH) and National Science Foundation (NSF). In October 2025, Symphony Robotics entered a strategic partnership with Monteris Medical to combine its MRI-guided micro-robotic arm with Monteris' NeuroBlate laser interstitial thermal therapy (LITT) system for treating brain tumors and drug-resistant epilepsy. The company is led by Founder and CEO Mordechai Avisar and Chief Medical Officer Neil Martin, with a headcount of 1-10 employees.

The business model is pre-commercial. Once FDA clearance is obtained, Symphony Robotics is expected to generate revenue primarily through direct enterprise sales of its micro-robotic platform hardware to hospitals and neurosurgical centers, with potential supplemental revenue from training, implementation, and technical support services. Distribution will likely be executed through direct sales to major neurosurgical centers, with the Monteris Medical partnership potentially providing an additional channel via NeuroBlate's installed base. Pricing has not been publicly disclosed.

Name

Symphony Robotics

Legal name

Symphony Robotics

Website

https://symphonyrobotics.health

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Symphony Robotics is a Miami-based medical device company developing an MRI-guided, AI-controlled steerable micro-robotic platform for minimally invasive brain surgery, targeting neurosurgeons treating inaccessible brain tumors and drug-resistant epilepsy lesions. Technology is pre-FDA and pre-revenue.

Ownership category

akta.pro rank

Product category

Neurosurgical Robotics

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)

akta.pro secondary industries

Healthcare & Assistive Robotics (HDAAAIAC), Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT) (HLAHADAG), Movement Disorders (Parkinson’s, Tremor, Dystonia) (HLAKAIAC)

Keywords

• Neurosurgical robotics
• MRI-guided ablation
• Micro-robotic surgery
• Brain tumor treatment
• Minimally invasive neurosurgery

Headquarters

HQ city

Miami

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

1. Micro-Robotic Platform Hardware Sales: Pre-revenue company. The technology is currently investigational and under development, not yet cleared or approved by the FDA for clinical use. Once commercialized, the company is expected to generate revenue through the sale of its micro-robotic platform hardware to hospitals and surgical centers.
2. Professional Services and Training: Potential revenue stream from training, implementation support, and ongoing technical support services for hospital and medical center customers adopting the technology.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Symphony Robotics develops an MRI-guided, magnetically actuated micro-robotic platform controlled by AI algorithms that navigates through the brain along non-linear, snake-like trajectories. The system enables neurosurgeons to deliver energy, perform biopsies, and precisely deliver therapeutic agents to multiple deep brain targets through a single minimally invasive entry point, addressing lesions previously considered inaccessible to conventional rigid surgical tools.

Product overview

Symphony Robotics offers a single unified product: its MRI-guided steerable micro-robotic platform. This platform combines AI-powered navigation with magnetically actuated flexible robotics to enable minimally invasive brain procedures. The system is designed to work in conjunction with existing surgical tools (such as laser ablation systems) to treat hard-to-reach brain pathologies. The company is backed by $12M+ in NIH and NSF funding and over a decade of research validation.

Differentiator

Problem solved

Functional benefit

Products and services

• MRI-Guided Steerable Micro-Robotic Platform An MRI-guided, magnetically actuated micro-robotic platform with AI-controlled navigation that bends, steers, and maneuvers through complex brain anatomy along non-linear, snake-like trajectories. Designed for neurosurgeons at hospitals and medical centers to deliver energy, perform biopsies, and precisely deliver therapeutic agents to multiple deep brain targets through a single minimally invasive entry point.

Quantifiable outcome

• Single minimally invasive entry point replaces multiple invasive procedures for multi-target treatment

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature3 records

Partnerships

One partnership is on record.

• Monteris MedicalcoreStrategic or Co-development Partner · 1 October 2025Strategic partnership to advance robotics for brain ablation surgery. Combines Symphony's MRI-guided, magnetically actuated micro-robotic arm with Monteris' NeuroBlate laser interstitial thermal therapy (LITT) system. Integrates AI-powered, flexible micro-robotic guidance with laser energy delivery to enable more precise, micro-invasive surgeries through non-linear trajectories within the brain. The collaboration aims to develop, launch, and commercialize the combined technology for treating brain tumors and drug-resistant epilepsy.

Scale indicators5 records

Recent moves4 records

Expansion highlights4 records

Broad incumbents

• Brainlab: Brainlab is a major provider of neurosurgical navigation, planning, and intraoperative imaging software widely used in brain surgery. As an established incumbent in MRI-guided neurosurgical workflows, it is a broad competitor that could integrate or develop flexible robotic guidance capabilities.
• Zimmer Biomet (ROSA): Zimmer Biomet's ROSA robotic platform is used across neurosurgical and orthopedic procedures. As an established surgical robotics incumbent with neurosurgical applications, it is a broad peer competing for the same hospital capital purchasing cycles.
• Carl Zeiss (ZEISS Surgical Microscopy):
• Stryker (Neurosurgical portfolio): Stryker offers neurosurgical instruments, navigation, and the MAKO surgical robot platform. It is a broad incumbent with both neurosurgical and adjacent robotic surgery assets that could compete with or acquire capabilities similar to Symphony's.
• Medtronic (StealthStation / Hugo): Medtronic offers StealthStation surgical navigation for neurosurgery and the Hugo surgical robot platform. Its neurosurgical navigation installed base and capital resources make it a broad incumbent that competes for neurosurgical procedure volumes and could develop competing MRI-guided robotic capabilities.

Direct peers

• Renishaw (Neuromate): Renishaw's Neuromate is a stereotactic neurosurgical robotic system used for brain biopsy, electrode placement, and other neurosurgical procedures. It competes in the same neurosurgical robotics category Symphony targets and represents a direct precedent for robotic neurosurgery platforms.
• Monteris Medical: Monteris Medical manufactures the NeuroBlate laser interstitial thermal therapy (LITT) system used in MRI-guided brain ablation. It is Symphony Robotics' strategic co-development partner and the most directly comparable peer, as Symphony's micro-robotic arm is being integrated with NeuroBlate for the same neurosurgical ablation procedures.
• Synaptive Medical: Synaptive Medical provides neurosurgical visualization, planning, and robotic-assisted surgery tools (e.g., Modus V, BrightMatter). It directly competes in MRI-based neurosurgical workflows and represents a comparable emerging neurosurgical technology peer.

Emerging players

• Globus Medical (ExcelsiusGPS): Globus Medical's ExcelsiusGPS is a robotic navigation platform expanding into cranial and spine procedures. As a growing surgical robotics player extending into neurosurgery, it represents an emerging competitor to Symphony's neurosurgical robotics focus.
• Penumbra: Penumbra develops neurovascular and minimally invasive neurosurgical technologies, including aspiration and embolization systems. It is an emerging player in the broader minimally invasive neurosurgery market that could overlap with Symphony's targeted therapy delivery applications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/symphonyrobotics

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Symphony Robotics